MedTrace Logo

hucMSCs Exosomes for the Treatment of Active Ulcerative Colitis

NCT06853522 · Status: NOT_YET_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-04-27

No results posted yet for this study

Summary

To evaluate the safety and efficacy of hUC-MSCs-Exos in the treatment of ulcerative colitis.

Conditions

  • Ulcerative Colitis (UC)

Interventions

DRUG

exosomes derived from human umbilical cord mesenchymal stem cells

The corresponding exosome content of 60×10\^6 umbilical cord mesenchymal stem cells was given

DRUG

saline +5% albumin

Equal amount of saline +5% albumin was given

Sponsors & Collaborators

  • Shanghai East Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-30
Primary Completion
2027-04-04
Completion
2028-04-04

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06853522 on ClinicalTrials.gov